The Centre for Medicines Discovery aims to catalyse the discovery and development of new medicines for patients.
LATEST NEWS
How can X-ray technology help in Covid research?
23 July 2021
Professor Frank von Delft is co-founder of the Moonshot project, which is a collaboration of expertise from all over the world. Thanks to the light beam work at Diamond, chemists now know the virus' weak spots and can work on developing a new anti-viral drug.
Crystal Structure-Guided Design of Bisubstrate Inhibitors and Photoluminescent Probes for Protein Kinases of the PIM Family
20 July 2021
The Bullock group is happy to contribute to this new report by Nonga et al describing the crystal structure-guided design of bisubstrate inhibitors and photoluminescent probes for protein kinases of the PIM Family.
Chemogenomics for drug discovery: clinical molecules from open access chemical probes
12 April 2021
A key focus of the CMD is the development of small molecule chemical probes to investigate the biology of interesting, disease-relevant protein targets. An often touted benefit of probes is that they accelerate the drug discovery process by providing a starting point for small molecule drugs, but is this really the case? This review seeks to answer that question by describing a number of probes that have gone on to inspire a variety of clinical molecules, and will hopefully encourage drug discoverers to turn to chemical probes for inspiration.
Highlights
TREM2: A TEP for Neuroscience & Neurological Disorders
The Target Enabling Package on #TREM2 for #AlzheimersDisease includes investigations on binding modes & functional activity of scFv antibody fragments. In collaboration with @ARUK_ODDI @karolinskainst @thesgconline @KTHresearch @EisaiUS & VivaBiotech. https://doi.org/10.5281/zenodo.5256633
LATEST PUBLICATIONS
-
Proteomic analysis of machine perfusion solution from brain dead donor kidneys reveals that elevated complement, cytoskeleton and lipid metabolism proteins are associated with 1-year outcome.
Journal article
van Leeuwen LL. et al, (2021), Transpl Int, 34, 1618 - 1629
-
Discovery of a Potent Dual SLK/STK10 Inhibitor Based on a Maleimide Scaffold.
Journal article
Serafim RAM. et al, (2021), J Med Chem
-
Identification, mapping and relative quantitation of SARS-CoV-2 Spike glycopeptides by Mass-Retention Time Fingerprinting.
Journal article
Chalk R. et al, (2021), Commun Biol, 4
